Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation

Código QR

Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation

Guardado en:

Detalles Bibliográficos
Autores principales:	Moira Taylor, Ana Valdes, Guruprasad Aithal, Stephen Bawden, Penny Gowland, Jane Grove, Amina Al-Awadi, Amrita Vijay
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/4777b48486494df696273f6fcf1653b3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Smoking results in accumulation of ectopic fat in the liver
por: Kato A, et al.
Publicado: (2019)

Circulating branch chain amino acids and improvement in liver fat content in response to exercise interventions in NAFLD
por: Xiulin Shi, et al.
Publicado: (2021)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Paria Zarghamravanbakhsh, et al.
Publicado: (2021)

Isoenergetic replacement of fat by starch in diets for African catfish (Clarias gariepinus): effect on water fluxes in the gastro intestinal tract.
por: Till S Harter, et al.
Publicado: (2013)

The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action
por: Piotr Zabielski, et al.
Publicado: (2018)

Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver
por: Ebrahim Abbasi, et al.
Publicado: (2021)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
por: Pegah Golabi, et al.
Publicado: (2022)

Correlation between Non-Alcoholic Fatty Liver Disease (NAFLD) fibrosis score (NFS) with Left Ventricular Mass Index (LVMI) in patients with NAFLD
por: Tri Ferry Rachmatullah, et al.
Publicado: (2021)

Faradaic junction and isoenergetic charge transfer mechanism on semiconductor/semiconductor interfaces
por: Mingzhi Chen, et al.
Publicado: (2021)

Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets
por: Stefan Kabisch, et al.
Publicado: (2021)

Novel screening model of obstructive sleep apnea for snorers with suspected NAFLD undergoing liver sonography
por: Yang-Bor Lu, et al.
Publicado: (2021)

Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation
por: Victoria L. Slaughter, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
por: Sue Shea, et al.
Publicado: (2021)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Li Y, et al.
Publicado: (2021)

Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver
por: Qi Su, et al.
Publicado: (2021)

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
por: Mujdat Zeybel, et al.
Publicado: (2021)

Subclinical steatohepatitis and advanced liver fibrosis in health examinees with nonalcoholic fatty liver disease (NAFLD) in 10 South Korean cities: A retrospective cross-sectional study.
por: Eun-Hee Nah, et al.
Publicado: (2021)

Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)
por: Shivali S. Joshi, et al.
Publicado: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
por: Daniela Maria Tanase, et al.
Publicado: (2021)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Osama Hamdy, et al.
Publicado: (2021)

Effect of cranberry supplementation on liver enzymes and cardiometabolic risk factors in patients with NAFLD: a randomized clinical trial
por: Kourosh Masnadi Shirazi, et al.
Publicado: (2021)

Glycaemic variability in diabetes: a tool for assessing the quality of glycaemic control and the risk of complications
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

Quantification of Liver Fat Content after Radiofrequency Ablation for Liver Cancer: Correlation with Hepatic Perfusion Disorders
por: Li-Shan Shen, et al.
Publicado: (2021)

Exposure to High-Fat Style Diet Induced Renal and Liver Structural Changes, Lipid Accumulation and Inflammation in Intact and Ovariectomized Female Rats
por: Sucedaram Y, et al.
Publicado: (2021)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Tingfeng Wu, et al.
Publicado: (2021)

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
por: Atul Goyale, et al.
Publicado: (2021)

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation
por: Lucía Barbier-Torres, et al.
Publicado: (2020)

Effect of Long-Term Exercise on Liver Lipid Metabolism in Chinese Patients With NAFLD: A Systematic Review and Meta-Analysis
por: Ye Gao, et al.
Publicado: (2021)

Sea Lions Develop Human-like Vernix Caseosa Delivering Branched Fats and Squalene to the GI Tract
por: Dong Hao Wang, et al.
Publicado: (2018)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Satoru Hagiwara, et al.
Publicado: (2021)

Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
por: Xuerong Wen, et al.
Publicado: (2021)

Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD
por: Anna-Sophia Leven, et al.
Publicado: (2021)

Immunohistochemical Identification of AQP1 in Livers of the High-fat Diet Rats
por: Wang,Jinbao, et al.
Publicado: (2019)

GI Bill of Rights, 1944
Publicado: (2017)

Whole Liver Radiotherapy- An Underutilized Weapon for Diffuse Liver Metastasis: A Case Report
por: Prakash Pandit, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
por: Abo-Amer YEE, et al.
Publicado: (2020)

MRI assessment of ectopic fat accumulation in pancreas, liver and skeletal muscle in patients with obesity, overweight and normal BMI in correlation with the presence of central obesity and metabolic syndrome
por: Pieńkowska J, et al.
Publicado: (2019)

A comparison of liver fat fraction measurement on MRI at 3T and 1.5T.
por: Lavanya Athithan, et al.
Publicado: (2021)

Vertical sleeve gastrectomy induces distinctive transcriptomic responses in liver, fat and muscle
por: Chang Ho Ahn, et al.
Publicado: (2021)